May myo-inositol and d-chiro-inositol (40:1) treatment be a good option on normal-weighted polycystic ovary syndrome patients without insulin resistance?
Eser ColakEmel Ebru OzcimenYusuf Aytac TohmaMehmet Ufuk CeranPublished in: The journal of obstetrics and gynaecology research (2020)
Our results showed that MI:DCI (40:1) treatment may be a first-line treatment in normal-weight PCOS patients without insulin resistance.